Literature DB >> 7806486

Central trajectories of type II (thin) fibers of the auditory nerve in cats.

Y V Morgan1, D K Ryugo, M C Brown.   

Abstract

This paper describes the central projections of thin fibers of the auditory nerve in cats. Both thin (type II) and thick (type I) fibers are labeled by extracellular injections of horseradish peroxidase (HRP) into the auditory nerve. Type I and almost all type II fibers bifurcate upon reaching the auditory nerve root of the cochlear nucleus. For a given bundle of auditory nerve fibers labeled by a discrete injection of HRP, bifurcations of type II and type I fibers are restricted to a narrow region of the nerve root. After the bifurcation, the pathways of type II branches within the anteroventral cochlear nucleus (AVCN) and posteroventral cochlear nucleus (PVCN) are similar to those of type I branches. This similarity in bifurcation and course of type I and type II fibers was observed in the ventral as well as dorsal parts of the ventral cochlear nucleus. The complete axonal course of most type II fibers could not be reconstructed, however, due to fading of the reaction product. Type II fibers produce very few collaterals in the cochlear nucleus (CN), but possess many 'en passant' swellings along their main processes and collaterals. Compared with type II fibers previously studied in mice (Berglund and Brown, 1989; 1994; Brown and Ledwith, 1990), cat type II fibers are similar in their general projections within the main body of the nucleus and in the frequency of 'en passant' swellings per length of fiber, but cat fibers have a higher percentage of 'complex' or pedunculated 'en passant' swellings.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7806486     DOI: 10.1016/0378-5955(94)90128-7

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  7 in total

1.  Outer Hair Cell Glutamate Signaling through Type II Spiral Ganglion Afferents Activates Neurons in the Cochlear Nucleus in Response to Nondamaging Sounds.

Authors:  Catherine J C Weisz; Sean-Paul G Williams; Chad S Eckard; Christopher B Divito; David W Ferreira; Kristen N Fantetti; Shenin A Dettwyler; Hou-Ming Cai; Maria E Rubio; Karl Kandler; Rebecca P Seal
Journal:  J Neurosci       Date:  2021-02-11       Impact factor: 6.167

2.  Auditory nerve fibers excite targets through synapses that vary in convergence, strength, and short-term plasticity.

Authors:  Xiao-Jie Cao; Donata Oertel
Journal:  J Neurophysiol       Date:  2010-08-25       Impact factor: 2.714

3.  Attenuation of noise-induced hyperactivity in the dorsal cochlear nucleus by pre-treatment with MK-801.

Authors:  M W Criddle; D A Godfrey; J A Kaltenbach
Journal:  Brain Res       Date:  2018-01-09       Impact factor: 3.252

4.  Synaptic transfer from outer hair cells to type II afferent fibers in the rat cochlea.

Authors:  Catherine J C Weisz; Mohamed Lehar; Hakim Hiel; Elisabeth Glowatzki; Paul Albert Fuchs
Journal:  J Neurosci       Date:  2012-07-11       Impact factor: 6.167

5.  Tyrosine Hydroxylase Expression in Type II Cochlear Afferents in Mice.

Authors:  Pankhuri Vyas; Jingjing Sherry Wu; Amanda Zimmerman; Paul Fuchs; Elisabeth Glowatzki
Journal:  J Assoc Res Otolaryngol       Date:  2016-09-30

6.  Co-occurrence of Hyperacusis Accelerates With Tinnitus Burden Over Time and Requires Medical Care.

Authors:  Fatma Refat; Jakob Wertz; Pauline Hinrichs; Uwe Klose; Hesham Samy; Rafeek Mohamed Abdelkader; Jörg Saemisch; Benedikt Hofmeier; Wibke Singer; Lukas Rüttiger; Marlies Knipper; Stephan Wolpert
Journal:  Front Neurol       Date:  2021-03-18       Impact factor: 4.003

7.  Endogenous retrovirus insertion in the KIT oncogene determines white and white spotting in domestic cats.

Authors:  Victor A David; Marilyn Menotti-Raymond; Andrea Coots Wallace; Melody Roelke; James Kehler; Robert Leighty; Eduardo Eizirik; Steven S Hannah; George Nelson; Alejandro A Schäffer; Catherine J Connelly; Stephen J O'Brien; David K Ryugo
Journal:  G3 (Bethesda)       Date:  2014-08-01       Impact factor: 3.154

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.